This summary covers recent health news, including Eli Lilly's weight loss drug approval in China, IT outages affecting ...

Rep. Emanuel Cleaver said "something is wrong" with how Robert Courtney could be released because of a new law.

Darryl Ashley with Eli Lilly spoke with KCTV5 on the conviction of pharmacist Robert Courtney. This is a day to enjoy the ...

The end of a wild week for stocks saw traders looking past a massive outage that shook businesses around the globe to get ready for the start of the tech earnings season.

Eli Lilly has won approval from Chinese regulators to sell its weight-loss treatment tirzepatide in the country, the company ...

Competition is mounting in the weight loss sector as giants like Eli Lilly, Roche, Novo Nordisk and Pfizer explore oral ...

Gov. Eric Holcomb will be taking another international economic development trip this summer — this time to Australia and ...

Eli Lilly announces that its weight loss drug, tirzepatide, has been approved by Chinese regulators. This move intensifies ...

Indiana is home to 32 Australian businesses and two Singaporean-owned businesses, and several Indiana-based companies do ...

The Tema Obesity & Cardiometabolic fund has outperformed the market, rising by roughly 33% versus the market's growth of ...

Eli Lilly (NYSE: LLY) has achieved a major milestone by securing regulatory approval for its weight management drug, Mounjaro ...

Discover the complexities of determining the best GLP-1 medication for weight loss, as studies and medication adherence vary, in this article.